Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-6 R alpha

IL-6 R alpha

Brief Information

Name:Interleukin-6 receptor alpha subunit
Target Synonym:IL6RA,IL6RQ,IL6Q,Interleukin-6 Receptor alpha Subunit,sIL6R,gp80,IL-6R subunit alpha,Membrane glycoprotein 80,IL6R,Interleukin 6 Receptor,IL-6 Receptor Subunit Alpha,CD126 Antigen,IL-6R 1,IL-6RA,Interleukin-6 Receptor Subunit Alpha,IL-6R-Alpha,IL-6R-1,CD126
Number of Launched Drugs:3
Number of Drugs in Clinical Trials:12
Lastest Research Phase:Approved

Product ListCompare or Buy

Part of Bioactivity data

ILR-H5259-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Human IL-6 R alpha, Fc Tag (Cat. No. ILR-H5259) on Protein A Biosensor, can bind ActiveMax® Human IL-6, Tag Free(Cat. No. IL6-H4218) with an affinity constant of 35.9 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

CD6-H82E8-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Biotinylated Human IL-6 R alpha, Avitag,His Tag (Cat. No. CD6-H82E8) on SA Biosensor, can bind ActiveMax® Human IL-6, Tag Free(Cat. No. IL6-H4218) with an affinity constant of 73.1 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Synonym Name

IL6R,CD126,IL-6R-1,IL-6RA,IL6RA,IL-6R-alpha,IL6RQ,gp80

Background

Interleukin 6 receptor (IL6R) is also known as CD126 (Cluster of Differentiation 126) , is a potent pleiotropic cytokine that regulates cell growth and differentiation of various tissues, and is known particularly for its role in the immune response and acute phase reactions. IL6R is a protein complex consisting of a IL-6 receptor subunit (IL6R) and interleukin 6 signal transducer Glycoprotein 130. IL6R also denotes the human gene encoding this subunit. Alternatively spliced transcript variants encoding distinct isoforms have been reported. IL6R subunit also shared by many other cytokines. The soluble form of IL6R arises from proteolytic cleavage of membrane-bound IL6Rα, and acts agonistically by making the IL6 ligand accessible to the signal transducer gp130. Dysregulated production of IL6 and IL6R are implicated in the pathogenesis of several inflammatory diseases and malignancies such as multiple myeloma, rheumatoid arthritis, or osteoporosis, and it has been reported that a humanized anti-IL6R monoclonal antibody is a promising agent applicable to the therapeutic approach for IL6 driven diseases. Interleukin-6 receptor has been shown to interact with Interleukin 6 and Ciliary neurotrophic factor.

Clinical and Translational Updates

Related Molecule

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Sarilumab REGN-88; SAR-153191 Approved Sanofi, Regeneron Pharmaceuticals Inc Kevzara Japan Arthritis, Rheumatoid Sanofi 2017-05-22 Arthritis, Rheumatoid Details
Satralizumab RG-6168; SA-237 Approved Chugai Pharmaceutical Co Ltd Enspryng, エンスプリング EU Neuromyelitis Optica Roche Registration Gmbh 2020-06-29 Myasthenia Gravis; Neuromyelitis Optica Details
Tocilizumab MRA; HPM-1; MRA-SC; R-1569; rhPM-1; RG-1569; RO-48775533 Approved Chugai Pharmaceutical Co Ltd Actemra/RoActemra, 雅美罗, Actemra, RoActemra EU Coronavirus Disease 2019 (COVID-19) Roche Registration Gmbh 2005-04-11 Lymphoma, Non-Hodgkin; Polymyalgia Rheumatica; Urinary Bladder Neoplasms; Rejection of organ transplantation; Coronavirus Infections; Neuromyelitis Optica; Severe Acute Respiratory Syndrome; Coronary Disease; Takayasu Arteritis; Pulmonary Arterial Hypertension; Breast Neoplasms; Lymphoma, Follicular; Multicentric Castleman's Disease (MCD); systemic sclerosis-associated interstitial lung disease; Fever; Colorectal Neoplasms; Arthritis, Juvenile; Rejection in heart transplantation; Pulmonary Disease, Chronic Obstructive; Osteoarthritis; Uveitis; Uveitis, Posterior; Leukemia, Myeloid, Acute; Inflammation; Carcinoma, Squamous Cell; Lymphoma; Non-ST Elevated Myocardial Infarction; Kidney Failure, Chronic; Carcinoma, Hepatocellular; Diabetes Mellitus; Behcet Syndrome; Amyotrophic Lateral Sclerosis; Dermatomyositis; Rejection of renal transplantation; HIV Infections; Liver Neoplasms; Polymyositis; Craniopharyngioma; Hematopoietic stem cell transplantation (HSCT); Cytokine Release Syndrome; Motor Neuron Disease; Fam Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tocilizumab Biosimilar (qyuns) QX-003-S Phase 1 Clinical Arthritis, Rheumatoid Details
Tocilizumab biosimilar (AryoGen Pharmed) Phase 3 Clinical Aryogen Biopharma Arthritis, Rheumatoid Details
CMAB806 CMAB-806 Phase 3 Clinical Taizhou Maibo Taike Biotechnology Co Ltd Arthritis, Rheumatoid; Arthritis Details
Recombinant humanized anti-IL-6R antibody (Hisun Pharma) HS-628 Phase 3 Clinical Zhejiang Hisun Pharmaceutical Co Ltd Arthritis, Rheumatoid; Arthritis Details
Atexakin alfa SON-080; r-IL-6 Phase 2 Clinical Merck Serono, Weizmann Institute Of Science Peripheral Nervous System Diseases; Diabetic Neuropathies Details
Vobarilizumab ALX-0061; ANTI-IL-6R; 20A11-9mer-ALB11; Anti-IL-6R Nanobody Ablynx Details
VDJ-001 Phase 2 Clinical Beijing Vdjbio Co Ltd Arthritis, Rheumatoid; Multicentric Castleman's Disease (MCD) Details
Tocilizumab biosimilar (Fresenius kabi) MSB-11456 Phase 3 Clinical Merck Serono Arthritis, Rheumatoid Details
Olamkicept FE-301; TJ-301; CR-5/18; FE-999301 Phase 2 Clinical Conaris Research Institute Colitis, Ulcerative Details
Levilimab BCD-089 Phase 3 Clinical Biocad Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message